Do biomarker-based ABC-AF scores improve risk prediction compared to traditional risk scores in patients with atrial fibrillation not receiving oral anticoagulation?
The recalibrated ABC-AF scores provide improved risk estimation and decision support for AF patients not on oral anticoagulation compared to traditional scores.
The biomarker-based ABC-AF scores showed better discrimination than traditional risk scores and were recalibrated for precise risk estimation in patients not receiving oral anticoagulation. They can now provide improved decision support on treatment of an individual patient with AF.
Benz et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: